Home › Cervical Cancer › Pennsylvania
Cervical Cancer clinical trials in Pennsylvania
15 studies for Cervical Cancer are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
DESTINY-PANTUMOUR04
- Research Site, Philadelphia
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- Honickman Center ( Site 5033), Philadelphia
- Asplundh Cancer Pavilion ( Site 5002), Willow Grove
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 25, 2026 · NCT07216703Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
- UPMC Vision Institute, Monroeville
- University Ear, Nose, & Throat Eye & Ear Institute, Pittsburgh
- UPMC Magee-Womens Hospital, Pittsburgh
- and 3 more
RecruitingPhase 4
Ages 18 and older · Women · Updated Sep 25, 2026 · NCT06952660PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
- Lancaster General Health - Ann B. Barshinger Cancer Institute, Lancaster
- University of Pennsylvania, Philadelphia
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 17, 2026 · NCT05758688Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Research Site, Philadelphia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06535607A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Philadelphia
- Normunity Investigational Site, Philadelphia
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07182149PopSci CHW4CervixHealth
- Thomas Jefferson University, Philadelphia
RecruitingHealthy volunteers welcome
Ages 25 to 65 · Women · Updated Aug 11, 2026 · NCT07336134Distance-Based Exercise to Preserve Function and Prevent Disability
- UPMC Hillman Cancer Center at Butler Health System, Butler
- IRMC Cancer Center, Indiana
- UPMC Hillman Cancer Center - New Castle, New Castle
- and 2 more
Recruiting
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT07059884Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC Hillman Cancer Center, Pittsburgh
RecruitingHealthy volunteers welcome
Ages 25 and older · Women · Updated Jul 31, 2026 · NCT07281430A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
- Abington Memorial Hospital, Abington
- University of Pennsylvania Health System, Perelman Center for Advanced Medicine, Philadelphia
- Magee - Womens Hospital of UPMC, Pittsburgh
- and 3 more
Recruiting
Ages 18 and older · Women · Updated Jul 30, 2026 · NCT04831580Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- University of Pittsburg Medical Center (UPCM), Pittsburgh
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 11, 2026 · NCT05283330Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
- UPMC Hillman Cancer Center, Pittsburgh
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT07223424A Study of VET3-TGI in Patients With Solid Tumors
- UPMC- Hillman Cancer Center, Pittsburgh
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 7, 2026 · NCT06444815SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Philadelphia
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774Reducing Urban Cervical Cancer Disparities
- Thomas Jefferson University, Philadelphia
- Fox Chase Cancer Center, Philadelphia
RecruitingHealthy volunteers welcome
Ages 18 to 90 · Women · Updated Oct 26, 2024 · NCT06416150From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.